MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Founder effect in (TTTTA)exp(TTTCA)exp and pure (TTTTA)exp in familial cortical myoclonic tremor with epilepsy type 1-SAMD12 locus

    ZD. Cen, XH. Chen, HT. Wang, DH. Yang, F. Zhang, Y. Chen, S. Chen, LB. Wang, P. Liu, F. Xie, B. Wang (Hangzhou, China)

    Objective: To detect the founder effect between familial cortical myoclonic tremor with epilepsy type 1 (FCMTE1) patients with (TTTTA)exp(TTTCA)exp (exp, expansion) in SAMD12 and healthy controls with…
  • MDS Virtual Congress 2021

    Progression of Syndrome Specific Metabolic Brain Patterns in Patients with Various Parkinsonian Syndromes

    M. Perovnik, K. Krejan, P. Tomše, E. Rebec, U. Simončič, L. Jensterle, L. Ležaić, M. Trošt (Ljubljana, Slovenia)

    Objective: To analyse the follow-up changes in the expression of the three syndrome specific metabolic patterns in a cohort of parkinsonian patients who underwent 18F-FDG…
  • MDS Virtual Congress 2021

    Unravelling Voice Tremor In Movement Disorders: A Machine Learning Study

    F. Asci, P. Di Leo, G. Ruoppolo, G. Saggio, G. Costantini, A. Berardelli, A. Suppa (Pozzilli (is), Italy)

    Objective: The aim of this study is to achieve a direct and objective discrimination between voice samples recoded from patients with essential tremor and dysphonia…
  • MDS Virtual Congress 2021

    Outcome of Movement Disorders affected by Covid-19: case series from a single Movement Disorders Unit

    M. Demirkiran, G. Aktan, M. Balal (Adana, Turkey)

    Objective: The aim of this study is to investigate the effects of corona virus (Covid-19) infection on patients with movement disorders. Background: Since the outbreak…
  • MDS Virtual Congress 2021

    Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.

    G. Lopez, V. Kurtz, B. Charra, E. Garino, D. Ballesteros (Buenos Aires, Argentina)

    Objective: To determine the impact of extended quarantine during the COVID-19 pandemic in PD patients. Background: Due to the Covid-19 pandemic, various types of social…
  • MDS Virtual Congress 2021

    Progressive encephalomyelitis with rigidity and myoclonus in a Mexican patient

    R. Garcia-Bermudez, D. Leon-Castillo, B. Bertado-Cortes (Mexico City, Mexico)

    Objective: To present a case report of a Mexican patient with a progressive encephalomyelitis with rigidity and myoclonus (PERM) with a good response to steroids.…
  • MDS Virtual Congress 2021

    Emotional, logistical and ethical aspects of voluntarily stopping eating and drinking in patients with movement disorders

    J. Shurer, M. Buchbinder, N. Browner (Chapel Hill, USA)

    Objective: We present two patients with atypical parkinsonism who chose to die by voluntarily stopping eating and drinking (VSED) to highlight the unique support and care needs associated…
  • MDS Virtual Congress 2021

    Visuo-cognitive training in Parkinson’s disease: Protocol for a randomised cross-over trial.

    J. Das, R. Morris, G. Barry, R. Walker, S. Stuart (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the feasibility and potential effects of a technological visuo-cognitive training (TVT) intervention in people with Parkinson’s (PwP). Background: Visual and cognitive impairments…
  • MDS Virtual Congress 2021

    Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact of Concomitant Antiemetics on Nausea and Vomiting

    R. Hauser, S. Factor, W. Ondo, I. Zhang, E. Pappert, B. Navia (Tampa, USA)

    Objective: Analyze the effect of concomitant trimethobenzamide (TMB) on nausea and vomiting rates in patients with Parkinson’s disease (PD) receiving apomorphine sublingual film (APL) for…
  • MDS Virtual Congress 2021

    OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson’s Disease and Motor Fluctuations

    P. Lewitt, O. Klepitskaya, L. Bahroo, G. Liang, S. Rattana, J. Trotter, M. Serbin (West Bloomfield, USA)

    Objective: To conduct a longitudinal real-world study that examines treatment patterns, clinical outcomes, safety and tolerability of opicapone as an adjunctive treatment to carbidopa/levodopa (CD/LD)…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley